| Name | Title | Contact Details |
|---|
Carefx Corporation is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.
Since 1965, Telecare has been committed to making a difference in the lives of people with serious mental illness. We believe in Recovery, and in the human ability and desire to reach its full potential. We have created an environment that puts the
Call9 is a technology company innovating medical services and systems in EmergencyMedicine and PalliativeCare.
FibroGen is a research-based biotechnology company using its expertise in connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology to discover, develop, and commercialize novel therapeutics for serious unmet medical needs. FibroGen’s research team is committed to discovering novel therapies in areas of major unmet medical need. Our goal is to continue to provide pipeline candidates supported by rigorous data in well-characterized therapeutic settings. All of FibroGen`s therapeutic candidates have been internally developed based on FibroGen`s pioneering research in two important areas of biology, hypoxia-inducible factor (HIF) and connective tissue growth factor (CTGF).
Channel Medsystems is a venture-backed company that was founded to bring innovation to the delivery of women’s healthcare. We strive to develop treatments to meet the unique needs of female patients and the high standards of their healthcare providers. We are committed to ensuring that patients have access to high quality outcomes that can be delivered in the convenience and comfort of their healthcare providers office.